Novartis AG Common Stock (NVS)
SG&A Expense Growth
3.29%
Quarterly · Period ending:
NVS SG&A Expense Growth
Latest reported3.29%period ending
Latest reported3.29%period ending
NVS Quarterly SG&A Growth (QoQ) (0.00% → 3.29%)
Latest values, visible window
High-resolution chart · PNG
NVS sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 3.2873% | |
| -8.6077% | |
| 3.8615% | |
| -3.8931% | |
| 12.5572% | |
| -12.6535% | |
| 11.7103% | |
| 1.3911% | |
| 8.838% | |
| -17.5377% | |
| 11.4203% | |
| 0% | |
| 6.918% | |
| -22.8449% | |
| 27.6226% | |
| -18.0117% | |
| 1.9647% | |
| -11.8695% | |
| 10.1437% | |
| -3.6228% | |
| 6.3757% | |
| -10.0663% | |
| 14.7704% | |
| 1.5143% | |
| -3.385% | |
| -10.7298% | |
| 10.031% | |
| -1.0042% | |
| 7.6577% | |
| -24.3869% | |
| 35.0506% | |
| -6.6953% | |
| 6.4251% | |
| -18.733% | |
| 9.8695% | |
| -3.3631% | |
| 9.6198% | |
| -9.5362% | |
| 12.8824% | |
| -6.8238% | |
| 10.4085% | |
| -14.9292% | |
| 12.186% | |
| -4.2577% | |
| 10.2072% | |
| -17.2257% | |
| 11.2202% | |
| -6.8217% | |
| 5.1966% | |
| -23.8484% | |
| 29.9946% | |
| -2.907% | |
| -10.2892% | |
| -9.0948% | |
| 13.5585% | |
| -6.069% | |
| 3.2273% | |
| -12.2632% | |
| 9.5075% | |
| -5.5149% | |
| 10.0522% | |
| -11.8311% | |
| 27.8802% | |
| 1.4371% | |
| 2.9018% | |
| -14.0115% | |
| 22.4082% | |
| -3.5957% | |
| 9.4854% | |
| -12.4084% | |
| 7.8477% | |
| -6.8213% | |
| 9.928% | |
| -9.3775% | |
| 15.6555% | |
| -4.4458% | |
| 8.4365% | |
| -8.1663% | |
| 14.3297% | |
| -1.3828% | |
| 9.8962% | |
| -13.9943% | |
| 11.2017% | |
| -1.5701% | |
| 5.3676% | |
| -7.8591% | |
| 19.5142% | |
| -4.1149% | |
| -3.2307% | |
| 9.8185% | |
| 2.5815% | |
| -0.4634% | |
| 9.7043% | |
| -29.3503% | |
| 58.7047% | |
| -9.9393% | |
| 0% | |
| 0% | |
| 0% | |
| -100% |